Large Adcock Shareholder Expects Block Of CFR Bid To Pay Off
This article was originally published in PharmAsia News
Executive Summary
South Africa's Public Investment Corp. said that despite the continued unprofitability of Adcock Ingram Holdings, it still expects its role in blocking a sale to Chile's CFR Pharmaceuticals to pay off.